Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
28 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-adalvo-limited-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-ocular-inflammation-and-pain-302465602.html
06 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-announces-licensing-agreement-with-apotex-inc-for-commercialization-of-clobetasol-propionate-ophthalmic-suspension-for-post-ocular-surgery-inflammation-and-pain-for-mexico-302447818.html
06 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-almac-discovery-announce-licensing-agreement-for-alm-401-a-first-in-class-bispecific-adc-targeting-egfrror1-for-the-treatment-of-solid-tumors-302447143.html
25 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-saval-corporation-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-post-operative-inflammation-and-pain-302438865.html
18 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cipla-and-formosa-sign-multi-regional-licensing-deal-for-clobetasol-suspension-302403405.html
28 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-medvisis-switzerland-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-post-operative-inflammation-and-pain-302318160.html
ABOUT THIS PAGE